The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,457.00
Bid: 1,456.00
Ask: 1,458.00
Change: -32.00 (-2.15%)
Spread: 2.00 (0.137%)
Open: 1,458.00
High: 1,459.00
Low: 1,453.00
Prev. Close: 1,489.00
SMSN Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Suspicion of Embezzlement by Officer or Employee

3 Mar 2017 09:14

RNS Number : 4617Y
Samsung Electronics Co. Ld
03 March 2017
 

Suspicion of Embezzlement by Officer or Employee

 

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) ("Company") announced that the special prosecutor investigating an influence-peddling scandal involving South Korea's president has indicted the Company's executives on allegations of embezzlement.

 

1. Relevant persons: Jae-Yong Lee (Vice Chairman), Gee-Sung Choi (Vice Chairman), Choong-Ki Chang (President),

Sang-Jin Park (President), Seong-Soo Hwang (Senior Vice President)

2. Amount of Embezzlement 

Amount of Suspicion

KRW 15,425,350,000

Total Equity of the Company

KRW 179,059,805,354,410

Ratio to Total Equity

0.009 %

3. Company's Response

- The Company will check on the progress of the investigation and the relevant process.

4. Date of occurrence: 02/28/2017

5. Date of confirmation: 03/03/2017

6. Other information

1) Details of the allegations are as follows:

- A violation of the Act on the Aggravated Punishment, etc. of Specific Economic Crimes

• The alleged amount:

KRW 15,425,350,000 joint and severally for Jae-Yong Lee (Vice Chairman), Gee-Sung Choi (Vice Chairman), and

Choong-Ki Chang (President)

Of the KRW 15,425,350,000, KRW 7,797,350,000 joint and severally for Sang-Jin Park (President) and Seong-Soo Hwang

(Senior Vice President)

2) The alleged amount described above is the amount applicable to the Company from the embezzlement amount indicated in the

indictment document.

3) The allegations and the alleged amount have not been finalized and are subject to change according to the court judgment.

4) Total equity described above is based on consolidated financial statement as of the end of 2015.

5) The Company will disclose any progress or additional details on this matter without delay.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMGGFLFFGNZG
Date   Source Headline
30th Apr 20248:10 amRNSTransactions with Affiliated Companies
30th Apr 20247:00 amRNSQuarterly Dividend for First Quarter 2024
30th Apr 20247:00 amRNS2024 1Q Earnings Release
30th Apr 20247:00 amRNS2023 Business Report
5th Apr 20247:11 amRNSNotice of 1Q 2024 Earnings Release Schedule
5th Apr 20247:00 amRNS1Q 2024 Pre-Earnings Guidance
20th Mar 20249:07 amRNSTransactions with Affiliated Companies
20th Mar 20249:05 amRNSResults of the 55th Annual General Meeting
21st Feb 20247:00 amRNSReference Material for 2024 AGM
20th Feb 20248:31 amRNSCharitable Contribution
19th Feb 20249:40 amRNS2023 Separate Financial Statements
19th Feb 20249:34 amRNS2023 Consolidated Financial Statements
31st Jan 20247:00 amRNSYear-End Dividend for FY2023
31st Jan 20247:00 amRNS2023 4Q Earning Release
31st Jan 20247:00 amRNSTransactions with Affiliated Companies
31st Jan 20247:00 amRNSShareholder Return Program for FY2024-2026
31st Jan 20247:00 amRNSAnnouncement of Capex Result for FY2023
9th Jan 20247:00 amRNSNotice of 4Q 2023 Earning Release
9th Jan 20247:00 amRNS4Q 2023 Pre-Earnings Guidance
1st Dec 202311:09 amRNSCharitable Contribution
30th Nov 20237:54 amRNSTransactions with Affiliated Companies
30th Nov 20237:34 amRNS2023 3Q Interim Business Report
6th Nov 20238:43 amRNSAnnouncement of Investor Relations Event
31st Oct 20237:21 amRNSTransactions with Affiliated Companies
31st Oct 20237:18 amRNSAnnouncement of Capex Plan for FY2023
31st Oct 20237:13 amRNSQuarterly Dividend for Third Quarter 2023
31st Oct 20237:10 amRNS2023 3Q Earning Release
11th Oct 20237:10 amRNSNotice of 3Q 2023 Earning Release
11th Oct 20237:04 amRNS3Q 2023 Pre-Earnings Guidance
21st Sep 20237:30 amRNS2022 Business Report
21st Sep 20237:29 amRNS2022 Separate Financial Statements
21st Sep 20237:29 amRNS2022 Consolidated Financial Statements
31st Aug 20238:15 amRNS2023 Half-year Business Report
27th Jul 20238:15 amRNSTransaction with Affiliate Company
27th Jul 20238:09 amRNSCharitable Contribution
27th Jul 20238:04 amRNSQuarterly Dividend for Second Quarter 2023
27th Jul 20238:03 amRNS2023 2Q Earning Release
7th Jul 20237:31 amRNS2Q 2023 Pre-Earnings Guidance
3rd Jul 202310:12 amRNSSustainability Report 2023
31st May 202310:15 amRNSCorporate Governance Report FY2022
31st May 20239:26 amRNSCorporate Governance Report FY2022
31st May 20239:22 amRNS2023 1Q Interim Business Report
28th Apr 20237:47 amRNS2022 Business Report
27th Apr 20238:09 amRNSCharitable Contribution
27th Apr 20238:07 amRNSQuarterly Dividend for First Quarter 2023
27th Apr 20238:05 amRNS2023 1Q Earning Release
13th Apr 20238:33 amRNSNotice of 1Q 2023 Earning Release
11th Apr 20237:00 amRNS1Q 2023 Pre-Earnings Guidance
15th Mar 202310:30 amRNSResults of the 54th Annual General Meeting
16th Feb 20237:49 amRNS2022 Separate Financial Statements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.